Tuberculosis in the era of anti-TNF-alpha therapy: Why does the risk still exist?

Tuberculosis in the era of anti-TNF-alpha therapy: Why does the risk still exist?

Rheumatoid arthritis is an autoimmune systemic disease characterized mainly by inflammatory compromise of diarthrodial joints. Multiple drug therapies have been developed to control the activity of rheumatoid arthritis, among them, the first line of disease-modifying antirheumatic drugs (DMARD), and...

Full description

Bibliographic Details
Main Authors: John-Leonardo Torres-Castiblanco, Jorge Alberto Carrillo, Daniel Hincapié-Urrego, Adriana Rojas-Villarraga
Format: Article
Language:English
Published: Instituto Nacional de Salud 2018-03-01
Series:Biomédica: revista del Instituto Nacional de Salud
Subjects:
Mycobacterium tuberculosis
tuberculosis
diagnosis
arthritis, rheumatoid
risk factor
tumor necrosis factor-alpha
biological therapy
infliximab
Colombia
Online Access:https://www.revistabiomedica.org/index.php/biomedica/article/view/3458

Internet

https://www.revistabiomedica.org/index.php/biomedica/article/view/3458

Similar Items